The Entire Spectrum of Digital Health Care at the DMEA 2022

26 - 28 April 2022, Berlin, Germany.
From 26 to 28 April the DMEA on the Berlin Exhibition Grounds will present papers, an exchange of expert knowledge and workshops covering a wide spectrum of digital healthcare topics. The overall programme will provide the framework for discussions between more than 120 participants from science and practice on current and future subjects of vital importance in digital healthcare.

Read more ...

Working Visit of Franz Fayot to Germany: Signing of a Cooperation Agreement for the Development of Digital Health Applications and Value-Added Services for the HE:AL Campus

On the last day of the working visit of the Minister of the Economy Franz Fayot to Germany, the Luxembourg delegation visited the digital health cluster Medical Valley in Erlangen in Bavaria. The Medical Valley European Metropolitan Region Nuremberg (EMN) is a leading international innovation ecosystem in the field of healthcare management.

Read more ...

Innovative AI Technology Aids Personalized Care for Diabetes Patients Needing Complex Drug Treatment

Hitachi, Ltd. (TSE: 6501, Hitachi), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment. One in 10 adults worldwide have been diagnosed with type 2 diabetes,

Read more ...

DMEA 2022: Digital Health - Opening the Door on Careers

26 - 28 April 2022, Berlin, Germany.
Almost every industry is desperately in search of skilled workers, whether in nursing, IT, the skilled trades or industry - and digital health is no exception. Clever minds are needed to ensure that in the future software, apps and technology will continue to be developed and optimised. This year, DMEA is again providing a platform for making contact with digital health companies, networking and meeting potential employers of the future.

Read more ...

AI Enables Personalized Treatment of Myocarditis

Myocarditis (inflammation of the heart muscle) is usually caused by viruses, e.g. in COVID-19 disease. However, it can also be induced by medication, toxic substances or in the context of a rheumatological disease. Clinical assessment is difficult due to widely varying symptoms, from fatigue to chest pain, palpitations, shortness of breath, and, rarely, sudden cardiac death, the latter associated with sports activity.

Read more ...

NHS Tayside Sign Up to Early Warning System Miya Observations

NHS Tayside has signed a five-year agreement with smart health tech provider Alcidion to deploy Miya Observations, an electronic monitoring system that will help thousands of busy healthcare professionals as they care for patients.

Read more ...

Automation and Digitalization: Solutions within AUTOMA+ Healthcare 2022

26 - 27 September 2022, Zurich, Switzerland.
AUTOMA + Healthcare gathers leaders from hospitals & healthcare providers, pharmaceutical companies, governmental bodies and institutions with the main goal to contribute to further development of ongoing digital health trends. AUTOMA+ Healthcare is organized as a place to present case-studies, exchange experience in digital transformation and network.

Read more ...

Pilot Study Suggests AI could Help Assess, Improve Heart Transplant Outcomes

Heart transplantation can be a lifesaving operation for patients with end-stage heart failure. However, many patients experience organ transplant rejection, in which the immune system begins attacking the transplanted organ. But detecting transplant rejection is challenging - in its early stages, patients may not experience symptoms, and experts do not always agree on the degree and severity of the rejection.

Read more ...

AI Provides Accurate Breast Density Classification

An artificial intelligence (AI) tool can accurately and consistently classify breast density on mammograms, according to a study in Radiology: Artificial Intelligence.

Breast density reflects the amount of fibroglandular tissue in the breast commonly seen on mammograms. High breast density is an independent breast cancer risk factor, and its masking effect of underlying lesions reduces the sensitivity of mammography.

Read more ...

Ground-Breaking Leicester Atrial Fibrillation Management Goes Virtual

People in Leicester experiencing an irregular heart rhythm are set to benefit from virtual monitoring thanks to a new innovation at Leicester's Hospitals.

University Hospitals of Leicester NHS Trust has become one of the first in the UK to create a remote monitoring ward for patients with atrial fibrillation.

Read more ...